OSLO, Norway, Nov. 10, 2025 /PRNewswire/ — Reference is made to the press release issued by GreenH AS on November 7, 2025, announcing that the company has taken investment decisions and is progressing its hydrogen projects as planned. Nel ASA (Nel) (OSE: NEL) is pleased to announce that it has entered into an agreement with GreenH to be the technology provider for the Enova-supported projects in Kristiansund and Slagentangen.
GreenH develops, builds, owns, and operates hydrogen production facilities based on renewable energy. The company aims to establish a network of distributed hydrogen production sites to enable decarbonization in the maritime, transport, and industrial sectors. GreenH focuses on scalable solutions located close to end users, reducing logistics costs and supporting the development of efficient, regional hydrogen value chains.
The facilities in Kristiansund and Slagentangen are intended to supply green hydrogen to industrial and maritime users and form part of GreenH’s broader efforts to establish a network of distributed hydrogen production in Norway.
“We have worked together with Nel on finding the right electrolyser concept for Kristiansund and Slagentangen over a longer period. We are very pleased with the signing of this agreement and thereby bringing in Nel as a partner on these two projects that are very important for GreenH,” says Morten Solberg Watle, CEO of Green H AS
“We are pleased to support GreenH in developing regional hydrogen infrastructure in Norway, and we look forward to working together as they move forward,” says Håkon Volldal, CEO and President of Nel ASA.
Nel has entered into an agreement regarding delivery of electrolyser equipment, including associated engineering and technical support. Final scope, size, and delivery schedules will be confirmed later, but will be minimum 10 MW per site, totaling more than 20 MW.
For additional information, please contact: Kjell Christian Bjørnsen, CFO, +47 917 02 097 Wilhelm Flinder, Head of IR, Communications & Marketing +47 936 11 350
About Nel ASA |www.nelhydrogen.com Nel has a history tracing back to 1927 and is today a leading pure play hydrogen technology company with a global presence. The company specializes in electrolyser technology for production of renewable hydrogen, and hydrogen fueling equipment for road-going vehicles. Nel’s product offerings are key enablers for a green hydrogen economy, making it possible to decarbonize various industries such as transportation, refining, steel, and ammonia.
HONG KONG SAR – Media OutReach Newswire – 10 November 2025 – CPA Australia’s regional survey about business technology adoption shows that most companies in Hong Kong have used artificial intelligence (AI) tools at different levels. Though the increasing AI application helps to improve productivity, it also transforms the hiring trends in the accounting and finance industry, and increases concerns on data protection and governance, according to the survey findings.
The result indicates the notable growth of AI adoption across markets in Asia Pacific, with 89 per cent of respondents said that they have adopted AI in the past 12 months, up from 69 per cent last survey. In Hong Kong, 88 per cent have applied AI such as ChatGPT, Copilot at the workplace. When asked about the level of AI adoption, 65 per cent respondents primarily used third-party tools in several areas or occasionally.
Dr Paul Sin, CPA Australia’s Greater China Councillor and Chair of Web3 & Emerging Technology Committee highlighted the gap between the awareness of AI and releasing the real value of AI, “Most respondents said that they used third-party AI tools, implying that the awareness of AI in Hong Kong is high. Yet, many companies are still at the Proof-of-Concept stage, which means they just use AI tools to improve productivity like handling repetitive tasks and automate process. In fact, the government and professional organisations can do more education to unleash the true value of AI, for example, to reinvent business models or transform workflows by using more advanced solutions like predictive analytics and agentic AI, eventually scale up to production-grade implementation to align with their strategic goals.”
The increasing prevalence of AI is transforming the recruitment trends across various industries including accounting and finance. While 42 per cent of respondents in Hong Kong said that there has been no change in hiring practices, or that is too early to say, 17 per cent said that their organisations have reduced the number of junior-level staff hired for the accounting and finance teams due to the adoption of AI.
Dr Sin highlighted the correlation between the hiring trend and the tasks being replaced by AI, “Survey shows that most respondents use AI for data analytics and research in their accounting and finance activities, and these tasks are usually carried out by junior staff. Clearly, AI can free them up from repetitive and tedious tasks, allowing them focus on more human-centric or strategic responsibilities such as advisory, decision-making and client engagement. The underlying skills are difficult to replace with technology such as creativity and judgement built from business experience. Grooming junior staff to take on these more advanced responsibilities takes time, so employers should consider balancing adoption of advanced technology with talent development for the organisation’s long-term growth.”
Dr Albert Wong, Deputy Chair of CPA Australia’s Greater Bay Area Committee added on, “AI is only replacing certain tasks, not humans. As AI develops, the recruitment standard for technical skills is rising because some tasks can be done effectively by technology. Employers will expect their future staff to be able to work alongside with AI to solve problems, use these technology solutions to add value to existing services and products, generate new ideas/options, and predict the future in various scenarios. The job market will become more competitive. Therefore, the younger generation and the existing employees must develop irreplaceable skills, particularly soft skills such as human-human and human-machine interaction, effective communication, creative and critical thinking, and professional scepticism.”
To keep up with the transformation, the Hong Kong SAR Government has an instrumental role to play. He called for policy support to build a future-ready workforce in Hong Kong. “The Government could collaborate with organisations and employers to upskill existing workforce on AI-centric training; offer subsidies to encourage SMEs to pilot/adopt different types of AI in their businesses and create internship schemes that give university students the opportunity to apply AI tools to real-world problem-solving.”
Data is the new oil for technology. Among the surveyed markets, Hong Kong respondents raised the most concerns about increasing data protection and privacy issues (26 per cent) from AI adoption. On a positive note, 72 per cent said that they had implemented cybersecurity in the past 12 months, and Hong Kong’s overall cybersecurity maturity is considerably high.
Mr Winson Woo, a member of CPA Australia’s Greater Bay Area Committee shared his views on data protection and governance, “Many technologies already have embedded AI functions, so AI adoption will continue to increase in the future. Organisations should establish an AI development roadmap to plan how to apply AI to achieve strategic goals, and how to measure the return of investment, as well as setting clear governance guidelines to ensure the ethical use of AI tools in the workplace.”
When discussing cybersecurity, he highlighted two emerging trends: Manage Security Operations Center (MSOC), a model of outsourcing security operations center (SOC) functions to third-party service providers to perform real-time detection and monitoring of cyber attacks and threats; and AI security, which protects AI systems from data breaches and misuse. He also emphasised the importance of staff training in data protection, “To reduce the risk of data leakage, companies should invest not only in technical software, but also in enhancing staff’s security awareness, to ensure that AI users understand which authorised data can be used in AI tools and which sensitive information cannot be disclosed.”
Mr Woo believes that the introduction of guidelines and regulations, such as the Personal Data (Privacy) Ordinance and the Protection of Critical Infrastructure (Computer System) Ordinance, will help to create an ethical environment that promotes innovation and technology in Hong Kong.
The survey collected responses from 1,117 accounting and finance professionals across markets in the Asia-Pacific such as Australia, mainland China, including 154 responses from Hong Kong.
Hashtag: #CPAAustralia
The issuer is solely responsible for the content of this announcement.
About CPA Australia
CPA Australia is one of the largest professional accounting bodies in the world, with nearly 175,000 members in over 100 countries and regions, including more than 22,500 members in Greater China. CPA Australia is celebrating its 70th anniversary in Hong Kong this year. Our core services include education, training, technical support and advocacy. CPA Australia provides thought leadership on issues affecting the accounting profession and the public interest. We engage with governments, regulators and industries to advocate policies that stimulate sustainable economic growth and have positive business and public outcomes. Find out more at cpaaustralia.com.au
Thai authorities arrested three offenders (Photo: MGR Online)
Thai border authorities arrested three foreign nationals after they illegally crossed from Cambodia into Thailand attempting to smuggle around 1,000 mobile SIM cards to Myanmar on 9 November.
Lao Foreign Minister Thongsavanh Phomvihane will visit North Korea from 11 to 15 November to strengthen bilateral ties and celebrate historic milestones.
Lao Foreign Minister Thongsavanh Phomvihane will make an official visit to the Democratic People’s Republic of Korea (DPRK) from 11 to 15 November at the invitation of his North Korean counterpart, Choe Son Hui.
The visit aims to strengthen long-standing bilateral friendship and commemorate two significant milestones, according to the Lao Ministry of Foreign Affairs: the 60th anniversary of the historic first meeting between former Lao leader Kaysone Phomvihane and North Korea’s then-President Kim Il Sung in Pyongyang on 28 October 1965, and the 50th anniversary of diplomatic relations between both countries.
During the visit, the Lao delegation will discuss expanding cooperation across multiple sectors and deepening bilateral ties.
This marks Thongsavanh’s second visit to North Korea in 2025. He previously accompanied President Thongloun Sisoulith’s delegation during the state visit on 7 to 8 October, where President Thongloun held official talks with North Korean leader Kim Jong Un.
The October visit celebrated the 80th anniversary of the Workers’ Party of Korea and reaffirmed decades of diplomatic cooperation through state ceremonies, a banquet, and visits to key Pyongyang landmarks, further strengthening cultural and political ties between the two nations.
HONG KONG, Nov. 10, 2025 /PRNewswire/ — Shanghai, November 10, 2025 – During the 8th China International Import Expo (CIIE), Sino Biopharmaceutical Limited (“Sino Biopharm“) and Shanghai MediTrust Health Technology Group Co., Ltd. (“MediTrust Health”) signed a strategic cooperation agreement. The two parties will carry out in-depth cooperation around innovative drugs and commercial insurance, jointly explore a new model of drug-insurance integration, and help more patients access high-quality, affordable medicines at an earlier stage.
Mr. Tse Hsin, Executive Director and Senior Vice President of Sino Biopharm, and Mr. Wang Rundong, President of MediTrust Health, attended the signing ceremony and delivered speeches. Mr. Li Zhigang, Chairman of MediTrust Health, was present as a witness.
Mr. Tse Hsin highlighted that as a leading Chinese innovative pharmaceutical group, Sino Biopharm generates annual revenue of approximately RMB 30 billion, ranks 38th among the Top 50 Global Pharmaceutical Companies, and has a pipeline of over 120 innovative drugs. With evolving demographics and deepening healthcare reforms, commercial health insurance has become a critical channel for innovative drugs to reach the market. This not only eases pressure on public medical insurance funds but also fuels R&D investment, fostering a sustainable industry cycle.
He emphasized MediTrust Health’s role as a pivotal platform connecting pharmaceutical companies, insurers, and patients, giving it a unique edge in advancing “drug-insurance integration”. The two parties will further explore AI, data collaboration, and innovative payment solutions to set new benchmarks for industry coordination.
Mr. Wang Rundong noted that MediTrust Health remains patient-centric, leveraging AI and data-driven multi-payment infrastructure to streamline the “diagnosis-treatment-payment” journey. “We envision insurance as more than a reimbursement tool—it should be a bridge to better healthcare, ensuring patients facing critical illnesses gain earlier, more affordable access to treatment with greater peace of mind,” he said. The partnership aligns with the “Healthy China 2030” strategy, aiming to enhance drug accessibility and build a win-win ecosystem for the pharmaceutical and insurance sectors.
About Sino Biopharm
Sino Biopharm, is a leading Chinese pharmaceutical company continuing to invest in Oncology, Hepatology, Respiratory and Surgery, exploring innovative therapies to improve the lives of patients. The company has strong manufacturing capabilities and broad patient access across China. Sino Biopharm is committed to bringing innovation to address unmet healthcare needs globally.
MediTrust Health, as an innovative healthcare payor platform in China, is committed to transforming China’s healthcare payment system by addressing funding and payment challenges faced by patients, health insurers and pharmaceutical companies. With our AI-empowered technologies, we have augmented the healthcare payment ecosystem and realized triple wins for all three stakeholders. With a focus on the needs of patients, insurers and pharmaceutical companies, we have developed two main offerings: Smart Pharma Solution provides pharmaceutical companies with a comprehensive suite of commercialization solutions across the product lifecycle; Smart Insurance Solution enables health insurance innovation by offering end-to-end support to health insurers through our proprietary AI-empowered technologies and access to quality medical resources. Additionally, we have also launched Care2Pay, an all-in-one user platform, that allows users to discover more payment solutions and complete direct billing transactions, ultimately delivering more comprehensive, quality and accessible healthcare to patients and their families. As of December 31, 2024, we had serviced approximately 393 million commercial health insurance policies, of which our City Supplementary Insurance projects covered 160 cities, and achieved cumulative savings of RMB 6.7 billion in out-of-pocket costs for patients.
SHANGHAI, Nov. 10, 2025 /PRNewswire/ — On November 7, Jiahui International Cancer Center (JICC) successfully treated a 78-year-old patient from New Zealand with relapsed multiple myeloma using CAR-T therapy, highlighting JICC’s growing reputation as a destination for cutting-edge oncology care for international patients. The patient received Zevor-cel (Zevor-cel Injection) CAR-T therapy and was discharged in stable condition.
The patient, a retired family medicine doctor with 40 years of experience, had exhausted all conventional treatment options in his home country. Following a recommendation from his hematologist and extensive personal research, he chose JICC for Chimeric Antigen Receptor T-cell (CAR-T) therapy. China is a global leader in CAR-T development, ranking second only to the United States in clinical trials and patient volume, making it a key hub for this advanced treatment.
78yr old New Zealand patient after CAR-T treatment
“The entire treatment process at Jiahui was very professional, and I received meticulous care,” the patient said. “The nursing team, in particular, looked after me like a family member. The medical service here is world-class.” The patient also noted the hospital’s efficiency, stating that diagnostic imaging was completed quickly, with most reports available the next day—a turnaround he said would be uncommon in his home country.
The patient’s journey began with a remote consultation via Zoom with the Cancer Center’s multidisciplinary team, including Dr. Xuan Linli, Chief of Medical Oncology, and Dr. Hao Siguo, Chief Hematology Consultant. The team’s deep expertise and the hospital’s robust multidisciplinary support system—which includes hematology, critical care, and specialized nursing—convinced the patient to travel over 9,000 kilometers to Shanghai for the treatment.
In mid-September, the patient had his first planned trip to the hospital for tests and T-cell harvesting, before returning home. He returned to Shanghai in early October for hospital admission to receive the CAR-T cell infusion. Just two weeks later, the patient achieved complete minimal residual disease (MRD) negativity in his bone marrow, and free light chains (FLCs) returned to normal, confirming the successful efficacy of the CAR-T treatment.
JICC’s ability to rapidly onboard and manage the entire CAR-T treatment process—from T cell harvesting and infusion to inpatient monitoring and aftercare—coupled with the affordability of the procedure in China, makes it an increasingly attractive option for international patients.
Growing International Interest in JICC
The successful case is part of a broader trend. Jiahui International Cancer Center has received a growing number of inquiries on advanced oncology treatment from Europe, North America, Singapore, the Middle East, and South East Asia, including the United States, Canada, France, Switzerland, Greece, Belgium, Qatar, and Russia. In 2025, JICC has treated 24,000 international patients based in Shanghai, including 35 who traveled specifically for medical tourism. This reflects its commitment to providing world-class, patient-centered care.
About Jiahui International Hospital Jiahui International Cancer Center is part of Jiahui International Hospital, Shanghai’s first large-scale international tertiary hospital. Led by senior international oncology experts, JICC provides comprehensive cancer diagnosis and treatment services following international standards, having established a strategic partnership with the Massachusetts General Hospital Cancer Center.
Delivered by UNICEF with a broad consortium of local partners, the new grant will restore education for 180,000 children
NEW YORK, Nov. 10, 2025 /PRNewswire/ — Education Cannot Wait (ECW) and its strategic donor partners announced today a US$3.5 million grant to address the evolving Rohingya refugee crisis in Bangladesh through the transformational power of education.
The new funding builds on ECW’s US$50.7 million in total investments in Bangladesh, which have already reached over 386,000 children, 96% of whom are Rohingya refugees. In all, these investments have built or rehabilitated 2,300 classrooms, provided financial support to 2,700 educators, and delivered essential training on disaster-risk reduction, gender, mental health and psychosocial support and other key topics to teachers and administrators working on the frontlines of this forgotten crisis.
The fast-acting First Emergency Response will restore access to life-saving education for 180,000 children in Cox’s Bazar, Bangladesh, home to the largest refugee camp in the world.
Delivered by UNICEF – in partnership with local organizations including Community Development Centre (CODEC), Jagorani Chakra Foundation (JCF), BRAC, Mukti Cox’s Bazar, Friendship, and the COAST Foundation – the new grant will increase access to inclusive learning opportunities in safe and protective learning environments.
“Every child deserves the chance to learn, no matter the crisis,” said Rana Flowers, UNICEF Representative to Bangladesh. “This support from Education Cannot Wait is a lifeline. It is more than books and lessons – it is a child’s bridge to dignity, stability and the future they deserve. This support will help us give Rohingya children the skills, confidence and hope they need to rebuild their communities when it is safe to return home. The future of the Rohingya people – their culture, their identity, their voice – depends on the children learning today.”
Declining humanitarian assistance – including funding for education – is derailing hard-won gains in Bangladesh. As of June 2025, more than 3,600 learning facilities for early childhood through Grade 4 remain closed. Recent analysis indicates that only half of the Joint Response Plan has been mobilized to date.
Note to Editors
About Education Cannot Wait (ECW): Education Cannot Wait (ECW) is the global fund for education in emergencies and protracted crises in the United Nations. We support quality education outcomes for refugee, internally displaced and other crisis-affected girls and boys, so no one is left behind. ECW works through the multilateral system to both increase the speed of responses in crises and connect immediate relief and longer-term interventions through multi-year programming. ECW works in close partnership with governments, public and private donors, UN agencies, civil society organizations, and other humanitarian and development aid actors to increase efficiencies and end siloed responses. ECW urgently appeals to public and private sector donors for expanded support to reach even more vulnerable children and youth.
BEIJING, Nov. 9, 2025 /PRNewswire/ — A news report from China Daily:
In October, the ancestral home of Mazu on Meizhou Island, Fujian province, welcomed 30 youth delegates from around the world. Hailing from locations as diverse as Madagascar, France, Kenya, Malaysia, and Russia, they embarked on a journey to trace the origins and cultural influence of Mazu, the Goddess of the Sea.
The delegation kicked off their visit on the evening of Oct 30 with a trip to the Tianfei Hometown Archaeological Park. Under a calm night sky, they explored the historic site and its artifacts, learning about the millennia-old Mazu cultural tradition.
The following morning, the group travelled to Ewei Shenshi Yuan, a site of dramatic coastal rock formations that hold a key place in Mazu lore. “This place is filled with a mysterious aura, and the sea is so magnificent”, said Julie Rose Vilvandre from France, adding that the experience inspired her to share Mazu culture with a global audience.
Walking through the unique site, delegate Gitau Recheal Mugure from Kenya noted the powerful connection between the site and its natural surroundings. “I felt Mazu’s spirit of compassion everywhere. When I return to Kenya, I will take back not just photographs but a profound understanding of Chinese culture and the essence of Mazu.”
That afternoon, the group took part in the colorful and rhythmic “Mazu Returning Procession,” a centuries-old ceremony honoring Mazu’s promotion of kindness, courage and compassion. As night fell, the goddess’s story was brought to life through dance and music in the “Origins of Meizhou” performance, which left a strong impression on the group.
On the morning of November 1, the delegation visited the Mazu Ancestral Temple. Manoa Aro Vanona Ramamonjison from Madagascar was captivated by the site. “The solemnity and tranquility of the Mazu Ancestral Temple left me in awe. Every brick and tile seems to tell a story, allowing me to truly touch the deep roots of Mazu culture.”
Through these immersive experiences, the delegates gained a deeper understanding of Chinese culture and a firsthand look at the virtues that define Mazu’s spirit. For Leo Chong Ren from Malaysia, this meant understanding the profound link between Mazu and the land. “The spirit of Mazu will become a guiding force in my future life,” he said, capturing the lasting impression the cultural journey left on all participants.
cpaaustralia.com.au
